This most current twist while in the Lykos Therapeutics saga threatens A significant overhaul of the company’s strategy and route, with Musk ally and billionaire Trader Antonio Gracias showing to want to choose the business again toward its nonprofit drug improvement roots and a far more Doblinite philosophy.Does one both of those appreciate lear